Target intelligence / Profile preview

Ribosomal protein L36 pseudogene

Molecular classification
Pseudogene, Processed pseudogene (if derived from mRNA retrotransposition; the vast majority of ribosomal protein pseudogenes are processed[3][1][5]), Non-coding RNA (occasionally, if transcribed[1][5])
01

Overview

Ribosomal protein L36 pseudogene refers to a nonfunctional genomic sequence that closely resembles the ribosomal protein L36 gene (RPL36) but lacks the ability to produce a functional ribosomal protein. Pseudogenes arise through processes such as gene duplication, retrotransposition, or disabling mutations and are identified by their sequence homology to known functional genes, along with disruptions (e.g., premature stop codons or frameshifts) that prevent normal gene expression and protein production. The majority of RPL36 pseudogenes are processed, meaning they originate from reverse-transcribed mRNA copies reintegrated into the genome without regulatory regions, and they typically lack biological function. In rare cases, pseudogenes may be transcribed and exert minor regulatory roles, but these do not apply to drug targeting or classical molecular functions[1][3][5][6].\n\nKey notes:\n- Pseudogenes like ribosomal protein L36 pseudogene are prevalent in the genome but are generally regarded as \"junk DNA\" with no protein-coding potential and not active in disease or drug response[5][1].\n- Occasionally, pseudogenes may play regulatory or RNA-mediated roles, but there is no evidence of clinical or therapeutic impact for RPL36 pseudogenes specifically[1][7].\n- It is important not to confuse these with functional ribosomal protein genes, such as RPL36, which do have crucial biological roles[2][6].

Other names
RPL36 pseudogeneribosomal protein L36 non-functional homologprocessed RPL36 pseudogeneother locus-specific designations depending on genomic context
02

Biological functions

Other (pseudogenes do not encode functional proteins but may rarely exert regulatory RNA roles, such as acting as miRNA decoys or generating non-coding RNA[1][7])
03

Disease associations

Other (rarely, some pseudogenes are implicated in disease mechanisms via regulatory functions, but there is no evidence for ribosomal protein L36 pseudogenes specifically being involved in disease[1][5][7])

Beyond the preview

Go deeper on Ribosomal protein L36 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call